BAM
SANA icon

Bosun Asset Management’s Sana Biotechnology SANA Stock Holding History

Bosun Asset Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-96,221
Closed -$962K – 193
2024
Q1 		$962K Buy
+96,221
New +$721K 0.55% 46

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bosun Asset Management's SANA Position: Q2 2024 in Review

Bosun Asset Management sold out of Sana Biotechnology (SANA) in Q2 2024, closing a stake of 96,221 shares — an estimated $962K sold.

Bosun Asset Management first reported a position in SANA in Q1 2024 and held it in 1 quarter. The position peaked at $962K in Q1 2024. 147 funds tracked by Wall St. Rank hold SANA as of Q2 2024.

  • Bosun Asset Management reported no remaining Sana Biotechnology position as of Q2 2024 after selling out during the quarter.
  • Bosun Asset Management sold 96,221 Sana Biotechnology shares in Q2 2024, an estimated $962K.
  • Bosun Asset Management first reported a position in Sana Biotechnology in Q1 2024 and held it in 1 quarter.
  • Bosun Asset Management's Sana Biotechnology position peaked at $962K in Q1 2024.
  • 147 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2024.

Based on Bosun Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.